No Data
Snowflake's (SNOW) Cloud Edge: Positioned for Explosive Growth?
Wells Fargo Maintains Snowflake(SNOW.US) With Buy Rating, Maintains Target Price $200
Snowflake Raised to Overweight From Equal-Weight by Barclays
Microsoft, Workday Projected to Lead Software Comeback in 2025: Barclays
Today's Analyst Rating | Deutsche Bank Upgrades Boston Scientific to Buy, Morgan Stanley Upgrades Gilead Sciences to Buy
Jan 10, Wall Street analysts have updated their stock ratings today including $Boston Scientific(BSX.US)$ and $Gilead Sciences(GILD.US)$.
Barclays Upgrades Snowflake(SNOW.US) to Buy Rating, Maintains Target Price $190